[1]
Farahani, P. 2017. NON-SEVERE HYPOGLYCEMIA RISK DIFFERENCE BETWEEN SULFONYLUREA AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2-I) AS AN ADD-ON TO METFORMIN IN RANDOMIZED CONTROLLED TRIALS. Journal of Population Therapeutics and Clinical Pharmacology. 24, 2 (Jun. 2017), e32-e40. DOI:https://doi.org/10.22374/1710-6222.24.2.6.